SCHEMBL182910

SCHEMBL182910

Cc1cc(C)c(C)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15049694 0.71
SCHEMBL755488 0.71
SCHEMBL29108616 0.71
SCHEMBL10768398 0.71
SCHEMBL5402816 0.69
SCHEMBL17975248 0.69
SCHEMBL5028276 0.69
SCHEMBL12553331 0.69
SCHEMBL20844195 0.69
SCHEMBL7038286 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2992041-B1 METHODS FOR TREATING LIGNOCELLULOSIC MATERIALS VIRDIA INC (US) 2020-01-08 EP claimed
EP-2991998-B1 METHODS FOR PREPARING THERMALLY STABLE LIGNIN FRACTIONS VIRDIA INC (US) 2019-08-14 EP claimed
CN-105358608-B Method for preparing a thermally stable lignin fraction 威尔迪亚公司 2018-11-16 CN claimed
US-7582712-B1 Alpha-olefins polymerization catalyst FORMOSA PLASTICS CORPORATION, U.S.A. (US) 2009-09-01 US claimed
US-7435742-B2 Quinuclidine derivatives and pharmaceutical compositions containing the same LABORATORIOS ALMIRALL S.A. (ES) 2008-10-14 US claimed
US-20060094751-A1 Quinuclidine derivatives and pharmaceutical compositions containing the same ALMIRALL, S.A. (ES) 2006-05-04 US claimed
US-20050239841-A1 New compounds BIOVITRUM AB (SE) 2005-10-27 US claimed
WO-2005051381-A1 Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R) BIOVITRUM AB (SE) 2005-06-09 WO claimed
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US claimed
EP-1515968-A2 QUINUCLIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Almirall Prodesfarma AG (CH) 2005-03-23 EP claimed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO claimed
WO-2004000840-A2 QUINUCLIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME ALMIRALL PRODESFARMA AG (CH) 2003-12-31 WO claimed
US-12624373-B2 Process for producing anhydrosugar(s) from lignocellulosic biomass UNITED ARAB EMIRATES UNIVERSITY (AE) 2026-05-12 US disclosed
US-20260071244-A1 PROCESS FOR PRODUCING ANHYDROSUGAR(S) FROM LIGNOCELLULOSIC BIOMASS UNIV UNITED ARAB EMIRATES (AE) 2026-03-12 US disclosed
CN-115397961-B Metal-free catalyst and hydrogen-free process for selective reduction of aldehydes of different substituted furans to methyl groups 科学与工业研究委员会 2025-05-20 CN disclosed
EP-4400172-A2 PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS Incyte Holdings Corporation (US) 2024-07-17 EP disclosed
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 EP disclosed
US-4992534-A Anticarcinogenic agents with better water solubility, low toxicity, absorption and stability OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-02-12 US disclosed
EP-0303269-A2 2'-Deoxy-5-fluorouridine derivatives, process for preparing the same and the use thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-02-15 EP disclosed
EP-0242753-A1 Wood-protecting agent including dimethylalkyl amine and boric acid Dr. Wolman GmbH (DE) 1987-10-28 EP disclosed